VAERS Explorer
Back to explore

Report #2866151

Received Oct 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS3UNK—

Symptoms (1)

Extra dose administered

Symptom narrative

received 3rd dose of Shingrix; This non-serious case was reported by a pharmacist via interactive digital media and described the occurrence of extra dose administered in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: received 3rd dose of Shingrix). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date:09-OCT-2025 This case was reported by a consumer via interactive digital media. The patient received late 2nd dose of Shingrix. Patient received a third dose of Shingrix and it was considered a non-serious case.